• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1829500
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Unspecified Infection (1930)
Event Date 05/11/2023
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a: through f: the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the patient allegedly experienced infection.The current status of the patent is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.Medical records were provided.The medical record alleges the patient underwent the bard hickman central venous catheter placement, approximately sometimes later post catheter placement the patient developed with the bacteremia and the catheter was removed.Then yeah double lumen port was placed at the right internal jugular vein for the treatment of leukocytosis where the patient had a history of lupus, mast cell activation, chronic venous access dependence with bacteremia associated with the hickman catheter that was removed hand it was now cleared that the bacteremia and the recommended port for long time access.The placement procedure was taken place by making an insertion on the skin, blend and sharp dissection was used to create the subcutaneous port packet and the catheter was advanced through the pillar way sheep in which it positioned centrally with the help of fluoroscopic guidance, then the pillowy sheet was removed hand the hemostat is was achieved with the manual compression, the catheter was cut to its appropriate glenn to reach the mid right atrium.Then the port was slide into the subcutaneous packet.The final fluoroscopy showed the port, and the catheter was to be in good position without kings and terminator at the cavoatrial junction.The lumen of the ports was then accessed with the needle for immediate use and the reservoir were instilled big, concentrated heparin in the interim.Approximately seven months later and blood culture reporter methicillin resistant staphylococcus aureus infection, five days later the patient underwent the port removal procedure for the concern of port infection with bacteremia.The removal procedure was taken with the help of local anesthetic into the right upper chest where the incision was at the optimal location for port removal with the help of blunt and sharp dissection to free the port from the packet.The port associated with the catheter were removed intact and the port cavity was inspected and found to be free from debris or blood.The procedure went well without any immediate complication.Therefore, the investigation can be confirmed that the patient experienced bacterial infection.However, the relationship to the port is unknown.Furthermore, the clinical condition alleged in the complaint cannot be confirmed.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 12/2023), h6 (method).H11: d4 (medical device lot number), h6 (patient, result).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that five months and seventeen days post a port placement via the right internal jugular vein, the patient allegedly developed with bacterial infection with the blood culture resulted growth of methicillin resistant staphylococcus aureus bacteria.Reportedly, the infected port was removed.The current status of the patent is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key19114543
MDR Text Key340231036
Report Number3006260740-2024-01788
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027185
UDI-Public(01)00801741027185
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090512
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1829500
Device Lot NumberREGW1944
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/01/2024
Initial Date FDA Received04/16/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/01/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age23 YR
Patient SexFemale
-
-